Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis

by Vincenzi, Bruno, Nannini, Margherita, Fumagalli, Elena, Bronte, Giuseppe, Frezza, Anna Maria, De Lisi, Delia, Ceruso, Mariella Spalato, Santini, Daniele, Badalamenti, Giuseppe, Pantaleo, Maria Abbondanza, Russo, Antonio, Tos, Angelo Paolo Dei, Casali, Paolo, Tonini, Giuseppe
Published in Oncotarget (2015)